
Comtripsy 6.14mg/15mg Tablet
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Tipiracil (6.14mg) + Trifluridine (15mg)
Overview Comtripsy 6.14mg/15mg Tablet
OncoComb 6.14mg/15mg tablets combine two agents to combat metastatic colorectal cancer. This medication inhibits or reduces the proliferation of cancerous cells. Administer OncoComb 6.14mg/15mg with food, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; deviations or overdoses can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue use only under medical direction. Frequent side effects include anemia, neutropenia, weariness, nausea, thrombocytopenia, appetite loss, diarrhea, emesis, and pyrexia. Report any bothersome side effects to your doctor. Regular blood tests monitor blood cell counts and hepatic function. Inform your healthcare provider of all medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and lactation. Utilizing effective contraception is crucial for both partners throughout treatment to prevent conception.
Uses of Comtripsy 6.14mg/15mg Tablet
Colorectal cancer
Major Benefits of Comtripsy 6.14mg/15mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Comtripsy 6.14mg/15mg Tablet whole; do not fracture, pulverize, or chew it. Administer this medication with a meal.
Common Side effects of Comtripsy 6.14mg/15mg Tablet:
- Anemia (low number of red blood cells)
- Decreased white blood cell count (neutrophils)
- Fatigue
- Nausea
- Low blood platelets
- Decreased appetite
- Diarrhea
- Fever
- Vomiting
How to use Comtripsy 6.14mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the Comtripsy 6.14mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
How Comtripsy 6.14mg/15mg Tablet works:
The dual-action oncology tablet, Comtripsy 6.14mg/15mg, comprises two anti-cancer agents. Trifluridine inhibits DNA replication, thereby halting cancer cell proliferation. Concurrently, tipiracil extends trifluridine's lifespan within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Comtripsy 6.14mg/15mg Tablet may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Comtripsy 6.14mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the benefits against potential risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCAUTION
Maternal use of Comtripsy 6.14mg/15mg tablets necessitates caution while breastfeeding. Breastfeeding is advised against until the mother's treatment concludes and the medication is fully cleared from her system.
DrivingCONSULT YOUR DOCTOR
Driving ability may be affected by Comtripsy 6.14mg/15mg Tablet, though this is unconfirmed. Refrain from driving if concentration or reaction time is impaired.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely take Comtripsy 6.14mg/15mg tablets without any required dose modification.
LiverSAFE IF PRESCRIBED
Comtripsy 6.14mg/15mg tablets can be administered to patients with hepatic impairment without modification to the prescribed dosage.
What if you forget to take Comtripsy 6.14mg/15mg Tablet :
Should you forget a Comtripsy 6.14mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Comtripsy 6.14mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
